CBD Oil | 750 mg Full Spectrum Hemp Extract
CBD Oil | 750 mg Full Spectrum Hemp Extract
CBD Oil | 750 mg Full Spectrum Hemp Extract

CBD Oil | 750 mg Full Spectrum Hemp Extract

Regular price
Sale price
Shipping calculated at checkout.

  • Full spectrum CBD with whole food phytonutrients, terpenes, and essential fatty acids
  • Derived from non-GMO, pesticide-free, argonomic farmed industrial hemp
  • Compliant with the federal legal limit of less than 0.3% THC
  • Carried in hemp seed oil 
  • Graduated glass dropper to ensure easy dosing
  • Grown in the USA and processed in an FDA registered and inspected facility


  • Supports mental relaxation*
  • Supports body relaxation*
  • Supports physical and mental health*
  • Supports balance of homeostatic system*
 *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.


  • Quantity: 750 mg CBD in 30 mL organic hemp seed oil
    • Ready to refill after 1 to 4 months depending on use
  • Suggested Use: Start low and go slow- 0.25 ml indicated on the graduated dropper up to a 1 ml (one full dropper) once per day or as directed by a healthcare professional.
  • Price Per Day: $0.41 to $1.67 per day depending on use

According to a report published by the World Health Organization in 2017:

Cannabidiol (CBD) is one of the naturally occurring cannabinoids found in cannabis plants. In humans, CBD exhibits no effects indicative of any abuse or dependence potential. CBD has been demonstrated as an effective treatment of epilepsy in several clinical trials, with one pure CBD product (Epidiolex®).

There is also preliminary evidence that CBD may be a useful treatment for a number of other medical conditions. There is unsanctioned medical use of CBD based products with oils, supplements, gums, and high concentration extracts available online for the treatment of many ailments. CBD is generally well tolerated with a good safety profile. Reported adverse effects may be as a result of drug-drug interactions between CBD and patients’ existing medications. Several countries have modified their national controls to accommodate CBD as a medicinal product. To date, there is no evidence of recreational use of CBD or any public health related problems associated with the use of pure CBD.

For most indications, there is only pre-clinical evidence, while for some there is a combination of pre-clinical and limited clinical evidence. The range of conditions for which CBD has been assessed is diverse, consistent with its neuroprotective, antiepileptic, hypoxia-ischemia, anxiolytic, antipsychotic, analgesic, anti-inflammatory, anti-asthmatic, and antitumor properties.

Another possible therapeutic application which has been investigated is the use of CBD to treat drug addiction. A recent systematic review concluded that there were a limited number of preclinical studies which suggest that CBD may have therapeutic properties on opioid, cocaine, and psychostimulant addiction, and some preliminary data suggest that it may be beneficial in cannabis and tobacco addiction in humans. However, considerably more research is required to evaluate CBD as a potential treatment.

Reference: World Health Organization CBD Pre-Review Report Expert Committee on Drug Dependence November 2017: https://www.who.int/medicines/access/controlled-substances/5.2_CBD.pdf